Research Paper Volume 13, Issue 5 pp 7499—7516
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
Figure 6. Survival analysis for BDKRB2 in pan-glioma (A, D), LGG (B, E) and GBM (C, F).
Figure 6. Survival analysis for BDKRB2 in pan-glioma (A, D), LGG (B, E) and GBM (C, F).